EMBO Molecular Medicine

Share this on social media:

Wiley-Blackwell and EMBO have announced that EMBO Molecular Medicine has joined the Wiley Open Access publishing programme. Articles in the journal will be open access and free to view, download and share for non-commercial use.

Launched in 2009, EMBO Molecular Medicine attained a first impact factor of 8.833. Converting to open access allows all readers to benefit from the high-level research advances reported in the journal, aiding the dissemination of biomedical research and accelerating discovery, say the partners.